HHS orders more monkeypox vaccine
The Department of Health and Human Services July 1 ordered an additional 2.5 million doses of Bavarian Nordic's JYNNEOS, an FDA-licensed vaccine for prevention of smallpox and monkeypox, for use in responding to current or future monkeypox outbreaks and as part of the nation’s smallpox preparedness. Deliveries from this latest order will begin arriving at the Strategic National Stockpile later this year and will continue through early 2023.
This order brings the total vaccine doses to be delivered in 2022 and 2023 to more than 4 million. As of July 1, the CDC has reported approximately 460 U.S. cases of monkeypox.
Related News Articles
Headline
There have been 1,168 confirmed cases of measles across 33 states as of June 6 this year, according to the latest data from the Centers for Disease Control and…
Headline
A JAMA study published June 3 found that of 2,237 counties across the U.S., 78% reported declines in vaccination rates for measles, mumps and rubella from 2019…
Headline
There have been 1,024 confirmed cases of measles across the U.S. so far in 2025, according to the latest data from the Centers for Disease Control and…
Headline
There have been 1,001 confirmed cases of measles across the U.S. so far in 2025, according to the latest data from the Centers for Disease Control and…
Headline
Though seasonal flu activity is low or minimal across the country, 216 pediatric deaths associated with seasonal influenza virus infection have been tallied so…
Headline
The U.S. has had 935 confirmed cases of measles so far this year, according to the latest data from the Centers for Disease Control and Prevention. Cases have…